Cargando…

Biological and therapeutic role of LSD1 in Alzheimer’s diseases

Alzheimer’s disease (AD) is a common chronic neurodegenerative disease characterized by cognitive learning and memory impairments, however, current treatments only provide symptomatic relief. Lysine-specific demethylase 1 (LSD1), regulating the homeostasis of histone methylation, plays an important...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yu, Zhao, Yuanyuan, Li, Xiaona, Zhai, Liuqun, Zheng, Hua, Yan, Ying, Fu, Qiang, Ma, Jinlian, Fu, Haier, Zhang, Zhenqiang, Li, Zhonghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640401/ https://www.ncbi.nlm.nih.gov/pubmed/36386192 http://dx.doi.org/10.3389/fphar.2022.1020556

Ejemplares similares

Radix Rehmanniae Praeparata (Shu Dihuang) exerts neuroprotective effects on ICV-STZ-induced Alzheimer’s disease mice through modulation of INSR/IRS-1/AKT/GSK-3β signaling pathway and intestinal microbiota
por: Su, Yunfang, et al.
Publicado: (2023)

LSD1: biologic roles and therapeutic targeting
por: Maiques-Diaz, Alba, et al.
Publicado: (2016)

A state-of-the-art review on LSD1 and its inhibitors in breast cancer: Molecular mechanisms and therapeutic significance
por: Yang, Guan-Jun, et al.
Publicado: (2022)

Advances in the roles and mechanisms of lignans against Alzheimer’s disease
por: Han, Na, et al.
Publicado: (2022)

The neuroprotective effects of Liuwei Dihuang medicine in the APP/PS1 mouse model are dependent on the PI3K/Akt signaling pathway
por: Yuan, Ye, et al.
Publicado: (2023)

Role of the 5-HT(2A) Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin
por: Holze, Friederike, et al.
Publicado: (2021)

LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation
por: Kraehenmann, Rainer, et al.
Publicado: (2017)

Therapeutic Effects of Natural Drugs on Alzheimer’s Disease
por: Ma, Yuan, et al.
Publicado: (2019)

LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials
por: Noce, Beatrice, et al.
Publicado: (2023)

Emodin in cardiovascular disease: The role and therapeutic potential
por: Guo, Yuanyuan, et al.
Publicado: (2022)

LINC00586 Represses ASXL1 Expression Thus Inducing Epithelial-To-Mesenchymal Transition of Colorectal Cancer Cells Through LSD1-Mediated H3K4me2 Demethylation
por: Liu, Fengting, et al.
Publicado: (2022)

Therapeutic effects of total saikosaponins from Radix bupleuri against Alzheimer’s disease
por: Li, Juan, et al.
Publicado: (2022)

An Overview of Systematic Reviews of Chinese Herbal Medicine for Alzheimer’s Disease
por: Liu, Nanyang, et al.
Publicado: (2021)

LSD Administered as a Single Dose Reduces Alcohol Consumption in C57BL/6J Mice
por: Alper, Kenneth, et al.
Publicado: (2018)

A Mechanistic Exploratory Study on the Therapeutic Efficacy of Astragaloside IV Against Diabetic Retinopathy Revealed by Network Pharmacology
por: Zhao, Zhi-Hao, et al.
Publicado: (2022)

Decylubiquinone Inhibits Colorectal Cancer Growth Through Upregulating Sirtuin2
por: Li, Jinlian, et al.
Publicado: (2022)

3-Chloro-N′-(2-hydroxybenzylidene) benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy
por: Sarno, Federica, et al.
Publicado: (2018)

Integrated untargeted and targeted metabolomics to reveal therapeutic effect and mechanism of Alpiniae oxyphyllae fructus on Alzheimer’s disease in APP/PS1 mice
por: Zhou, Shengnan, et al.
Publicado: (2023)

The Role of NLRP3 Inflammasome in Alzheimer’s Disease and Potential Therapeutic Targets
por: Liang, Tao, et al.
Publicado: (2022)

Integrated comparative metabolomics and network pharmacology approach to uncover the key active ingredients of Polygonati rhizoma and their therapeutic potential for the treatment of Alzheimer’s disease
por: Wang, Fu, et al.
Publicado: (2022)

The therapeutic potential of ultra-short-acting β-receptor antagonists in perioperative analgesic: Evidence from preclinical and clinical studies
por: Fu, Linbin, et al.
Publicado: (2022)

Analgesic Effects and Safety of Dexmedetomidine Added to Nalbuphine or Sufentanil Patient-Controlled Intravenous Analgesia for Children After Tonsillectomy Adenoidectomy
por: Jia, Yingping, et al.
Publicado: (2022)

A Novel 5-HT(1B) Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer’s Disease
por: Yang, Yang, et al.
Publicado: (2021)

The interaction between cellular senescence and chronic kidney disease as a therapeutic opportunity
por: Zhao, Jing-Li, et al.
Publicado: (2022)

Role of matrix metalloproteinases in diabetic foot ulcers: Potential therapeutic targets
por: Fu, Kang, et al.
Publicado: (2022)

Therapeutic insights elaborating the potential of retinoids in Alzheimer’s disease
por: Behl, Tapan, et al.
Publicado: (2022)

Astragalus mongholicus Bunge (Fabaceae): Bioactive Compounds and Potential Therapeutic Mechanisms Against Alzheimer’s Disease
por: Dong, Qianyu, et al.
Publicado: (2022)

The Role of LSD1 and LSD2 in Cancers of the Gastrointestinal System: An Update
por: Malagraba, Gianluca, et al.
Publicado: (2022)

Therapeutic effect and mechanism of Anemarrhenae Rhizoma on Alzheimer’s disease based on multi-platform metabolomics analyses
por: Wang, Hui, et al.
Publicado: (2022)

HIF-1α in Osteoarthritis: From Pathogenesis to Therapeutic Implications
por: Zeng, Chu-Yang, et al.
Publicado: (2022)

Nationwide Case-Control Study Examining the Association between Tamoxifen Use and Alzheimer’s Disease in Aged Women with Breast Cancer in Taiwan
por: Liao, Kuan-Fu, et al.
Publicado: (2017)

In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease
por: Watt, Georgia, et al.
Publicado: (2017)

MicroRNAs in Alzheimer’s Disease: Diagnostic Markers or Therapeutic Agents?
por: Angelucci, Francesco, et al.
Publicado: (2019)

Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer’s Disease
por: Beggiato, Sarah, et al.
Publicado: (2019)

Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer's Disease
por: Rahman, Md. Habibur, et al.
Publicado: (2020)

NEU1—A Unique Therapeutic Target for Alzheimer’s Disease
por: Khan, Aiza, et al.
Publicado: (2022)

Evaluation of bumetanide as a potential therapeutic agent for Alzheimer’s disease
por: Boyarko, Ben, et al.
Publicado: (2023)

Deciphering the Roles of Metformin in Alzheimer’s Disease: A Snapshot
por: Liao, Wang, et al.
Publicado: (2022)

Sacubitril/Valsartan Improves Left Atrial and Left Atrial Appendage Function in Patients With Atrial Fibrillation and in Pressure Overload-Induced Mice
por: Suo, Ya, et al.
Publicado: (2019)

The critical roles and therapeutic implications of tuft cells in cancer
por: Li, Lin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vl5fjqqgb8o1dgq4leaqvvplb0